Objective: To provide a summary of published survey articles regarding the provision of medication therapy management (MTM) services in the United States. Methods: A literature search was conducted to identify original articles on MTM-related surveys conducted in the United States, involving community and outpatient pharmacists, physicians, patients, or pharmacy students and published by the primary researchers who conducted the study. Search engines used included PubMed, Medline, and International Pharmaceutical Abstracts (IPA). If MTM was in the keyword list, mesh heading, title, or abstract, the article was reviewed. References from these articles were searched to determine whether other relevant articles were available. Results: A total of 405 articles were initially reviewed; however, only 32 articles met the study requirements. Of the 32 articles, 17 surveyed community/outpatient pharmacists, 3 surveyed pharmacy students, 4 surveyed physicians, and 8 surveyed patients. The survey periods varied across the different studies, with the earliest survey conducted in 2004 and the most recent survey conducted in 2009. The surveys were conducted via the telephone, US mail, interoffice mail, e-mails, Internet/Web sites, hand-delivered questionnaires, and focus groups. Conclusion: Despite the identified barriers to the provision of MTM services, pharmacists reportedly found it professionally rewarding to provide these services. Pharmacists claimed to have adequate clinical knowledge, experience, and access to information required to provide MTM services. Pharmacy students were of the opinion that the provision of MTM services was important to the advancement of the pharmacy profession and in providing patients with a higher level of care. Physicians supported having pharmacists adjust patients’ drug therapy and educate patients on general drug information but not in selecting patients’ drug therapy. Finally, patients suggested that alternative ways need to be explored in describing and marketing MTM services for it to be appealing to them.
Summary of the executive sessions on medication therapy management programs, Bethesda, Maryland, June 14 and August 18, 2004. Am J Health Syst Pharm. 2005;62(6):585–592.
PellegrinoANMartinMTTiltonJJMedication therapy management services: definitions and outcomes. Drugs. 2009;69(4):393–406.
5.
McGivneyMSMeyerSMDuncan-HewittWMedication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc (2003). 2007;47(5):620–628.
6.
BlumlBM. Definition of medication therapy management: development of professionalwide consensus. J Am Pharm Assoc. 2005;45(5):566–572.
7.
American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication therapy management in community pharmacy practice: core elements of an MTM service (version 2.0). J Am Pharm Assoc. 2008;48(3):341–353.
8.
AMCP. Sound medication therapy management programs, version 2.0 with validation study. J Manag Care Pharm. 2008;14(1 suppl B):S2–S44.
9.
TouchetteDRBurnsALBoughMASurvey of medication therapy management programs under medicare part D. J Am Pharm Assoc (2003). 2006;46(6):683–691.
10.
BoydSTBoydLCZillichAJ. Medication therapy management survey of the prescription drug plans. J Am Pharm Assoc (2003). 2006;46(6):692–699.
11.
SchommerJCPlanasLGJohnsonKAPharmacist-provided medication therapy management (part 2): payer perspectives in 2007. J Am Pharm Assoc (2003). 2008;48(4):478–486.
12.
HansenRARothMTBrowerESMedication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand. J Am Pharm Assoc (2003). 2006;46(6):700–706.
13.
BeattySJRodisJLBellebaumKLCommunity and ambulatory pharmacy: evaluation of patient care services and billing patterns before implementation of medicare part D. J Am Pharm Assoc (2003). 2006;46(6):707–714.
14.
MoczygembaLRBarnerJCRobersonK. Texas pharmacists' opinions about and plans for provision of medication therapy management services. J Am Pharm Assoc (2003). 2008;48(1):38–45.
15.
SchommerJCPlanasLGJohnsonKAPharmacist-provided medication therapy management (part 1): provider perspectives in 2007. J Am Pharm Assoc (2003). 2008;48(3):354–363.
16.
GadkariASMottDAKrelingDHPharmacy characteristics associated with the provision of drug therapy services in nonmetropolitan community pharmacies. J Rural Health. 2009;25(3):290–295.
17.
MacIntoshCWeiserCWassimiAAttitudes toward and factors affecting implementation of medication therapy management services by community pharmacists. J Am Pharm Assoc (2003). 2009;49(1):26–30.
18.
LounsberyJLGreenCGBennettMSEvaluation of pharmacists' barriers to the implementation of medication therapy management services. J Am Pharm Assoc (2003). 2009;49(1):51–58.
19.
BlakeKBMadhavanSSScottVGMedication therapy management services in West Virginia: pharmacists' perceptions of educational and training needs. Res Social Adm Pharm. 2009;5(2):182–188.
20.
LawAVOkamotoMPBrockK. Ready, willing, and able to provide MTM services?: A survey of community pharmacists in the USA. Res Social Adm Pharm. 2009;5(4):376–381.
21.
BrightDRLengelAJPowersMF. Pharmacists' perceptions of barriers to implementing medication therapy management and the role of pharmacy technicians in overcoming the barriers. J Pharm Technol. 2009;25():361–365.
22.
ZhangSDoucetteWRUrmieJMFactors associated with independent pharmacy owners' satisfaction with medicare Part D contracts. Res Social Adm Pharm. 2010;6(2):121–129.
23.
BlakeKBMadhavanSS. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS. Ann Pharmacother. 2010;44(3):424–431.
24.
RicklesNMDubeGLMcCarterARelationship between attitudes toward mental illness and provision of pharmacy services. J Am Pharm Assoc (2003). 2010;50(6):704–713.
25.
HaagJDStrattonTP. Patient care services in rural Minnesota community pharmacies. J Am Pharm Assoc (2003). 2010;50(4):508–516.
26.
WangJHongSHMengSPharmacists' acceptable levels of compensation for MTM services: a conjoint analysis. Res Social Adm Pharm. 2011;7(4):383–395.
27.
RosenquistABestBMMillerTAMedication therapy management services in community pharmacy: a pilot programme in HIV specialty pharmacies. J Eval Clin Pract. 2010;16(6):1142–1146.
28.
ShahBChawlaS. A needs assessment for development and provision of medication therapy management services in new york city. J Pharm Pract. 2011;24(3):339–344.
29.
UrmieJMFarrisKBHerbertKE. Pharmacy students' knowledge of the medicare drug benefit and intention to provide medicare medication therapy management services. Am J Pharm Educ. 2007;71(3):41.
30.
KuhnCPowellPHSterrettJJ. Elective course on medication therapy management services. Am J Pharm Educ. 2010;74(3):40.
31.
GallimoreCEThorpeJMTrapskinK. Simulated medication therapy management activities in a pharmacotherapy laboratory course. Am J Pharm Educ. 2011;75(5):95.
32.
PadiyaraRSRabiSM. Physician perceptions of pharmacist provision of outpatient medication therapy management services. J Am Pharm Assoc (2003). 2006;46(6):660–663.
33.
AlkhateebFMClausonKAMcCaffertyRPhysician attitudes toward pharmacist provision of medication therapy management services. Pharm World Sci. 2009;31(4):487–493.
34.
AlkhateebFMUnniELatifDPhysician attitudes toward collaborative agreements with pharmacists and their expectations of community pharmacists' responsibilities in West Virginia. J Am Pharm Assoc (2003). 2009;49(6):797–800.
35.
McGrathSHSnyderMEDuenasGGPhysician perceptions of pharmacist-provided medication therapy management: qualitative analysis. J Am Pharm Assoc (2003). 2010;50(1):67–71.
36.
DoucetteWRWitryMJAlkhateebFAttitudes of Medicare beneficiaries toward pharmacist-provided medication therapy management activities as part of the medicare Part D benefit. J Am Pharm Assoc (2003). 2007;47(6):758–762.
37.
NauDPPacholskiAM. Impact of pharmacy care services on patients' perceptions of health care quality for diabetes. J Am Pharm Assoc (2003). 2007;47(3):358–365.
38.
LawAVOkamotoMPBrockK. Perceptions of medicare Part D enrollees about pharmacists and their role as providers of medication therapy management. J Am Pharm Assoc (2003). 2008;48(5):648–653.
39.
TruongHALayson-WolfCde BittnerMRPerceptions of patients on medicare Part D medication therapy management services. J Am Pharm Assoc (2003). 2009;49(3):392–398.
40.
GarciaGMSnyderMEMcGrathSHGenerating demand for pharmacist-provided medication therapy management: identifying patient-preferred marketing strategies. J Am Pharm Assoc. 2009;49(5):611–616.
41.
MoczygembaLRBarnerJCBrownCMPatient satisfaction with a pharmacist-provided telephone medication therapy management program. Res Social Adm Pharm. 2010;6(2):143–154.
42.
FriedrichMZgarrickDMasoodAPatients' needs and interests in a self-pay medication therapy management service. J Am Pharm Assoc (2003). 2010;50(1):72–77.
43.
LintonABaconTATriceSResults from a mailed promotion of medication reviews among Department of Defense beneficiaries receiving 10 or more chronic medications. J Manag Care Pharm. 2010;16(8):578–592.
44.
American Pharmacists Association. Development and implementation of curricula strategies in Medication therapy management by colleges and schools of pharmacy. http://www.pharmacist.com/MTM/CurriculaSummary. Accessed January 10, 2012.
45.
American Pharmacists Association. Medication therapy management digest. Perspectives on 2009: a year of changing opportunities. http://www.pharmacists.com/mtm. Accessed December 11, 2011.
46.
SnyderMEZillichAJPrimackBAExploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Social Adm Pharm. 2010;6(4):307–323.
47.
BrockKADoucetteWR. Collaborative working relationships between pharmacists and physicians: an exploratory study. J Am Pharm Assoc (2003). 2004;44(3):358–365.
48.
ZillichAJDoucetteWRCarterBLDevelopment and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective. Value Health. 2005;8(1):59–66.
49.
AnayaJPRiveraJOLawsonKEvaluation of pharmacist-managed diabetes mellitus under a collaborative drug therapy agreement. Am J Health Syst Pharm. 2008;65(19):1841–1845.
50.
KielPJMcCordAD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39(11):1828–1832.
51.
CranorCWBuntingBAChristensenDB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash). 2003;43(2):173–184.
52.
American Pharmacists Association. Medication therapy management digest. Tracking the expansion of MTM in 2010: Exploring the consumer perspective. http://www.pharmacists.com/mtm. Accessed December 11, 2011.
